Ericksonian Hypnosis Versus CBT for Prolonged Grief (NCT06398886) | Clinical Trial Compass
CompletedNot Applicable
Ericksonian Hypnosis Versus CBT for Prolonged Grief
Turkey (Türkiye)39 participantsStarted 2023-09-04
Plain-language summary
Effects of Ericksonian Hypnotherapy Versus Cognitive Behavioral Therapy on Prolonged Grief Among University Students in Istanbul: A Randomized None-clinical Controlled Trial
This randomized controlled trial explores the efficacy of Ericksonian Hypnotherapy versus Cognitive Behavioral Therapy (CBT) in mitigating symptoms of prolonged grief among university students in Istanbul. With a backdrop of transitional academic and socio-emotional challenges, 39 students who experienced significant loss and exhibited symptoms of prolonged grief were enrolled. Participants were randomly assigned to undergo Ericksonian Hypnotherapy, CBT, or placed on a waiting list (control group), each with 13 individuals. The study uniquely positions itself in Istanbul, leveraging the city's cultural context to examine grief processing in an urban, academically engaged population. Utilizing the Prolonged Grief Scale, Beck Depression Inventory, and SCL-90 Symptom Checklist for assessment, the interventions were evaluated for their effectiveness in reducing grief and associated psychological symptoms.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Age Range: Participants must be aged between 18 and 35 years.
* Loss Experience: Participants should have experienced the loss of someone significant.
* Grief Intensity: Participants must score 25 or above on the Prolonged Grief Scale (PG-13).
* Psychological Health: Participants should not exhibit other psychopathological symptoms, apart from those associated with grief, as measured by the Symptom Checklist-90 (SCL-90).
* Commitment to Participation: Participants must be able and willing to attend all 8 full sessions.
Exclusion Criteria
* Age Limitations: Individuals under 18 or older than 35 years are excluded.
* Psychiatric Health: Individuals with any psychiatric diagnosis or those who have been on psychiatric medication within the last year are excluded.
* Availability: Individuals who cannot commit to attending all 8 sessions are excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prolonged Grief Scale
Timeframe: Data were collected at baseline, midpoint (4 weeks), and post-intervention (8 weeks